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Abstract
The growing body of clinical and experimental data regarding electromagnetic field (EMF) bioeffects and their therapeutic
applications has contributed to a better understanding of the underlying mechanisms of action. This study reports that two
EMF modalities currently in clinical use, a pulse-modulated radiofrequency (PRF) signal, and a static magnetic field (SMF),
applied independently, increased the rate of deoxygenation of human hemoglobin (Hb) in a cell-free assay. Deoxygenation
of Hb was initiated using the reducing agent dithiothreitol (DTT) in an assay that allowed the time for deoxygenation to be
controlled (from several min to several hours) by adjusting the relative concentrations of DTT and Hb. The time course of Hb
deoxygenation was observed using visible light spectroscopy. Exposure for 10–30 min to either PRF or SMF increased the
rate of deoxygenation occurring several min to several hours after the end of EMF exposure. The sensitivity and biochemical
simplicity of the assay developed here suggest a new research tool that may help to further the understanding of basic
biophysical EMF transduction mechanisms. If the results of this study were to be shown to occur at the cellular and tissue
level, EMF-enhanced oxygen availability would be one of the mechanisms by which clinically relevant EMF-mediated
enhancement of growth and repair processes could occur.
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Identification of some of the mechanisms underlying EMF
bioeffects and their clinical applications [1] has contributed to the
development and more widespread use of more effective
therapeutic signals [2]. It is clear that EMF modulation of nitric
oxide signalling plays an important role in EMF therapeutics [2–
6]. However, there may be other transduction pathways through
which EMF signals could modulate tissue repair and growth. For
example, several recent studies have reported EMF effects on
human Hb in solution and erythrocyte suspensions, including
decreases in viscosity [7] and changes in impedance [8], dielectric
properties [9], dia- and para-magnetic properties [10], optical
absorption [11] and in vivo deoxygenation [12]. In addition,
radiofrequency mobile telephone signals have been shown to
decrease Hb oxygen affinity in vitro [13] and changes in infrared
absorption have been reported for low-frequency EMF [14]. Also,
enhanced oxygen delivery by Hb is under investigation as a
therapeutic strategy for the treatment of pathologies such as
ischemia from stroke, cardiac disease and diabetic ulcers [15].
Thus, the present study aimed to characterize the effects on the
rate of deoxygenation of human hemoglobin (Hb) in an in vitro cell-
free assay of a pulse-modulated radiofrequency (PRF) signal
currently in clinical use for treatment of pain, edema and chronic
wounds [1,2], and, applied independently, of a static magnetic
field (SMF), from permanent ceramic magnets constructed for
therapeutic applications and reported to reduce pain [1]. These
non-thermal EMF modalities were chosen for this study due to
their demonstrated efficacy in a variety of therapeutically relevant
settings [1–6]. The reducing agent dithiothreitol (DTT) was
employed for its ability to facilitate control of the time course of
Hb deoxygenation by adjusting the ratio of DTT/Hb [16]. This
study will show that exposure to PRF and SMF, yielded significant
increases in the rate of Hb deoxygenation in the presence of the
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reducing agent DTT, observable several minutes to several hours
after EMF exposure had ended.
Materials and Methods
Hemoglobin Preparation
Fresh human blood was obtained with written donor consent
and approved for research by the Blood Bank at S.Orsola-
Malpighi Hospital, Bologna according to the rules established by
Legislative Decree 03-03-2005, article 9, paragraph 3, published
in G.U. n. 85, 13.04.2005. Blood samples were also obtained from
one author (DM) in accordance with New York State Consoli-
dated Law, Public Health Article 24-A, Section 2442, without
written approval of the Institutional Review Board of the Albert
Einstein College of Medicine. Blood was drawn in EDTA
anticoagulant tubes, centrifuged at 1000 x g for 10 min and
plasma removed. The packed erythrocytes were then washed in
0.85% sodium chloride solution and centrifuged at 1000 x g for
10 min, 3 times. The packed, washed erythrocytes were then
hemolyzed using distilled water, the resulting solution centrifuged
at 1000 x g for 10 min, and the Hb-containing supernatant
recovered using a Pasteur pipette. Red cell ghosts were sedimented
by additional centrifugation, and the resulting solution containing
2–2.5 mM oxyHb (measured by visible light spectroscopy [17]),
was stored in 1.5 mL aliquots at 280uC until used for each
experiment. Ten mL reaction mixtures were prepared using 100–
120 mM Hb in 50 mM Hepes buffer (pH 7.2, Sigma-Aldrich,
USA), and deoxygenation initiated with 20 mM DTT at
2260.1uC. pH was checked with a digital pH meter (Fisher
AB15 BioBasic, USA) and carefully maintained at 7.2 for all
hemoglobin samples used in this experiment. Immediately upon
addition of DTT, the 10 mL reaction mixture volume was divided
into 1 mL aliquots in sealed 1.5 mL microfuge tubes. No attempt
was made to alter the gaseous environment within the tubes.
EMF Exposure
All hemoglobin samples were exposed to the ambient magnetic
field, which was measured using a digital Gauss/Tesla meter
(model 7010, F.W. Bell, USA) to be 40.562 mT, 59 degrees from
horizontal (vertical component = 34.762 mT, horizontal compo-
nent = 21.062 mT). The PRF signal is approved by the US FDA
for post-operative pain and edema. The signal consisted of a
27.12 MHz sinusoidal carrier (derived from the carrier frequency
reserved and cleared worldwide for short wave diathermy)
configured to operate nonthermally through pulse modulation in
4 ms bursts, repeating at 5 Hz and peak magnetic field amplitude
of 1061 mT (Roma3, Ivivi Health Sciences, San Francisco, CA,
USA). These pulse modulation parameters were chosen on the
bases of theoretical modelling and published reports of bioeffects
at the cellular level, and healing at the animal and clinical levels
[1–3,18–24]. The PRF signal was delivered with a 20 cm circular
single-turn antenna (coil) oriented vertically, creating a
1061065 cm region of field homogeneity in the central area of
the plane of the coil within which a plastic carrier held five upright
1.5 mL microfuge tubes, each containing 1 mL reaction volume.
Each Hb sample was contained in a cylindrical volume of 2.5 cm
in height and 0.8 cm diameter. For this target size, using Faraday’s
Law of Induction, the mean peak induced electric field is 361 V/
m. PRF field parameters were assessed and verified for each
experiment using a National Institute of Standards and Testing
traceable electrostatically shielded loop probe 1 cm in diameter
(model 100A, Beehive Electronics, Sebastopol, CA, USA)
connected to a calibrated 100-MHz oscilloscope (model 2012B,
Tektronix, Beaverton, OR, USA). The output of the loop probe
was calibrated at 27.12 MHz by measurement of output power
using a spectrum analyser (model 8567A, Hewlett Packard, New
York, NY, USA) and the probe calibration factor for conversion to
magnetic field amplitude at 27.12 MHz was certified and given by
the manufacturer. SMF exposure was delivered using circular
permanent ceramic magnets of 3.8 cm diameter and 1.3 cm
thickness, constructed for therapeutic applications (Magnetherapy,
West Palm Beach, FL, USA), and composed of compacted and
sintered strontium ferrite (SrO-6(Fe2O3)), encased in plastic. These
magnets are axially magnetized to have a single north (N) and a
single south (S) pole on each circular face, and manufactured to
produce highly uniform field strength across each face. For all
experiments, magnets were arranged with circular faces oriented
vertically with 1.1 cm gaps between the parallel surfaces. In order
to simultaneously expose five 1.5 mL microfuge tubes, two
1.1 cm-wide treatment regions were formed using a central
magnet flanked by pairs of magnets on either side. This
(NS)(NS)-gap-(NS)-gap-(NS)(NS) configuration produced two cy-
lindrical treatment regions of 1.1 cm width and 3.3 cm in
diameter with uniform magnetic field (to63%), in which the Hb
samples were exposed. Within each treatment region the
horizontal component of the magnetic field (perpendicular to the
magnet surface) was 18666 mT, a field strength similar to those
commonly employed in therapeutic applications [25]. The
maximal value of the horizontal and vertical components (both
parallel to the magnet surface) was 4.060.6 mT. SMF compo-
nents were measured using a digital magnetometer (Model 450,
gaussmeter with MMT-6J02-VG transverse Hall effect probe with
1 mm resolution, Lake Shore Cryotronics, Westerville, OH, USA).
For each experiment, five 1.5 mL microfuge tubes containing the
hemoglobin preparation were exposed to PRF or SMF for 10–
30 min, and 5 tubes were simultaneously exposed to ambient
geomagnetic conditions (control) on the laboratory bench,
approximately 3 meters away from exposed samples. At this
distance contributions from either PRF or SMF to the control
condition were undetectable. Temperature variations between
exposed and control samples were less than60.1uC [Fisher AB15
BioBasic, Waltham, MA, USA].
Spectrophotometric Analysis
After control and EMF exposure, triplicate 300 mL samples
were taken from each 1.5 mL microfuge sample tube, pipetted
into an open 96-well flat-bottom plate (Fisher Scientific, USA) and
the concentrations of oxy, deoxy and metHb were measured
spectrophotometrically (SpectraMax 190, Molecular Devices,
Sunnyvale, CA, USA). The plate remained in the spectropho-
tometer at 22uC during the reaction, and the time course of
deoxygenation was determined using the method of Benesch et al.
[17], which employs a weighted linear combination of optical
densities at 560, 576 and 630 nm to determine oxyHb, deoxyHb
and metHb concentrations. Stock Hb solutions (in Hepes, pH 7.2)
and spectra from Hb/DTT data at t = 0 (i.e. after 30 min EMF/
Control exposures) were assayed for oxy, deoxy and metHb at
560, 576 and 630 nm [17]. The mean ratio of deoxy/oxy for Hb
stock solutions was 3.9%60.8%. For the Hb/DTT data at t = 0,
the mean deox/oxy was 3.3%60.6%. The two datasets do not
differ significantly (P = 0.44, n= 5). The mean ratio of metHb/
oxyHb was 21.8%63.8% for stock solutions and 25.6%63.7% for
Hb/DTT data at t = 0, indicating no significant differences
(P = 0.33, n= 5). Optical densities at 540, 560, 576 and 630 nm
were measured immediately after EMF exposure and at successive
1 to 30 min intervals, until maximal deoxygenation was observed.
Calibration studies confirmed that the kinetics of deoxygenation
could be controlled by adjusting the ratio of DTT/Hb concen-
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trations [16]. Under the conditions stated above, deoxygenation
occurred between 140 and 160 min after EMF exposure.
Deoxygenation time was reduced by the addition of 5 M of urea
to between 60–85 min after EMF exposure. In the absence of
DTT, no significant deoxygenation of Hb occurred up to 3 hours
(data not shown). Changes in oxyHB concentration with time are
summarized in the figures, and maximal differences between
deoxy and metHb for EMF exposures vs controls are reported in
the text. All figures and data shown are the results of single
experiments that have been repeated 2–10 times.
Statistical Analysis
Results were compared using the Student’s t test, or one-way
repeated measures ANOVA with Holm-Sidak post hoc analysis, and
Fieller’s method for the variance of ratios, as required (Sigmastat
3.0, Systat, Chicago, IL) and are reported as means6SEM.
Significance was accepted at P#0.05.
Results
Immediately after 30 min of PRF or SMF exposure, no
differences in Hb visible light spectra between PRF, SMF and
control (ambient magnetic field only) samples were detected.
However, changes in visible light spectra were observed in the
540–630 nm region during the time of most rapid deoxygenation,
which occurred in this experiment at 140–160 min after EMF
exposure. Figure 1 illustrates typical visible light spectra for PRF,
SMF and control exposure conditions, drawn from a single
exposure tube for each EMF condition. Deoxygenation occurred
at an earlier time following PRF and SMF exposures (traces with
one peak), as compared to control samples exposed only to the
ambient geomagnetic laboratory environment (trace with two
peaks). In trials employing PRF exposure (n = 5 tubes for each
EMF exposure condition) using 20 mM DTT, 150 min after a
single 30 min exposure, PRF-treated samples exhibited a
30.8610.3% reduction in oxyHb as compared to controls
(14.661.3 mM vs. 21.162.5 mM, P,0.03) (Figure 2). Concomi-
tant, significant increases in deoxy Hb (86.961.1 mM vs.
82.861.8 mM, P,0.05) and metHb (42.261.4 mM vs.
37.161.4 mM, P,0.02) also occurred. For the ratio of DTT/
oxyHb concentrations employed in these trials (20 mM DTT;
120 mM oxyHb), 150 min corresponded to the time of most rapid
deoxygenation. Addition of 5 M urea to the reagent solution
decreased the time to required deoxygenate to approximately 65–
75 min after reaction initiation. For these conditions, the maximal
difference between PRF-treated and control samples occurred at
73 min, with PRF-treated samples showing a 70.569.7% reduc-
tion in oxyHb as compared to controls (8.562.1 mM vs.
28.866.3 mM, P,0.03) (Figure 3). Concomitantly, there were
significant increases in deoxy Hb (54.462.2 mM vs. 40.965.2 mM,
P,0.04) and metHb (73.461.4 mM vs. 61.062.3 mM, P,0.02).
Under similar conditions (30 mM DTT, 5 M urea, n= 5) SMF
treated samples (10–30 min exposure) underwent nearly complete
deoxygenation before the untreated (control) samples began to
deoxygenate (P,0.002 for 42 min,t,58 min). For these SMF
treated samples, the most rapid deoxygenation occurred approx-
imately 10 min earlier than for control samples (Figure 4). Under
these conditions, SMF-treated samples substantially completed
DTT-induced deoxygenation before untreated samples began to
lose O2, an effect that was visibly observable in the 96-well
spectrophotometer plate, as shown in the photo in Figure 5, taken
approximately 46 min after the reaction was initiated. Experi-
ments were also carried out for which: 1) Hb was treated with PRF
or SMF for 30 min prior to introduction into the deoxygenation
solution (20 mM DTT+5M urea in 50 mM Hepes) and 2) the
deoxygenation solution was treated with PRF or SMF for 30 min
prior to introduction of Hb. In both cases the difference between
PRF- or SMF-treated and control samples was not significant.
Also, 10 min and 30 min PRF and SMF treatment durations were
compared (in 20 mM DTT+5M urea in 50 mM Hepes), with no
significant differences observed in the time course of deoxygen-
ation. In the absence of DTT, no PRF or SMF effects were
observed on the Hb oxidation state. The SMF sensitivity of this
Hb deoxygenation assay was repeated at the University of
Bologna, Italy. Initial experiments were performed in New York
with Hb from a single donor, and subsequent trials in Bologna
used Hb from 3 different donors, with similar results.
Discussion and Conclusions
The results from this study indicate that exposure to either PRF
or SMF, applied independently, can alter the rate of DTT-induced
deoxygenation of human Hb in an in vitro cell-free preparation,
resulting in more rapid Hb deoxygenation. To the authors’
knowledge, this is the first report showing that PRF and SMF
produced similar effects in the same biological system, in the same
study. The rate of Hb deoxygenation is non-linear in time and is
dependent upon the ratio of DTT/HbO2. For this assay, the use
of DTT as a reducing agent is preferable to other reducing agents,
due to the ease with which the time to deoxygenation can be
controlled [16]. It is interesting to note that a similar EMF
sensitivity, for Hb exposed to a GSM mobile phone signal, was
observed using sodium dithionite [13]. This suggests that EMF
acted upon a functional aspect of the Hb deoxygenation process
itself, and that this effect was not specific to the reducing agent
employed in this study. The observation that EMF pre-treatment
of Hb alone, or of the deoxygenation solution itself, failed to yield
a significant effect suggests that both PRF and SMF exposures
acted upon the interaction of Hb with the deoxygenating solution.
The addition of 5 M urea reduced the time to deoxygenate and
rendered both the PRF and SMF effects more easily observable.
Urea creates an extended cloud of waters that only weakly
participates in the hydrogen bonding network of bulk water,
facilitating the loosening of the protein structure [26] and
destabilizing the water-oxyHb structures that act as key allosteric
mediators of the Hb T-R transition [27], thus reducing the energy
required to deoxygenate. However, it is unclear whether the
addition of urea affected the primary PRF or SMF transduction or
merely renders the EMF effects more easily observable. No
differences were observed between 10 and 30 min SMF and PRF
treatment durations. Effects were observable several min to several
hours after PRF or SMF exposure was removed, suggesting that
these EMF modalities modified protein/solvation structure in a
manner that altered the energy required for deoxygenation.
This study does not provide sufficient detail to allow for the
elucidation of the mechanisms of action of EMFs on hemoglobin,
or to determine if SMF and PRF act upon the same submolecular
targets to produce the effects observed here. Also, further studies
are required to determine the range of field parameters for which
this assay exhibits sensitivity. However, the sensitivity and
biochemical simplicity of the assay developed here suggests its
usefulness for future studies that may further establish basic
biophysical EMF transduction mechanisms. The PRF signal was
developed using a theoretical model for the effect of the induced
electric field on ion binding kinetics at protein aqueous interfaces
[1–3,18]. It should be noted that PRF transduction through the
induced electric field is distinct from the transduction pathway
involved in SMF effects, for which no electric field is present. This
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Figure 1. EMF effect on hemoglobin (Hb) visible light spectra. Spectra representative of the effects of pulsed radiofrequency (PRF) signal and
186 mT static magnetic field (SMF) on Hb visible light spectra during bHb)deoxygenation. Data shown are typical of samples drawn from a single
tube for each EMF exposure condition, shown here at 150 min after a single 30 min EMF exposure. Deoxygenation of 100 mM Hb was carried out in
50 mM Hepes buffer (pH 7.2) using the reducing agent dithiothreitol (20 mM) at 22uC, and is characterized here by the passage of the spectrum from
a two-peaked to one-peaked form. Deoxygenation occured at an earlier time for EMF exposed samples (traces with one peak), as compared to
control samples exposed only to the ambient geomagnetic laboratory environment (trace with two peaks). The EMF effect was observable at the
time of most rapid deoxygenation.
doi:10.1371/journal.pone.0061752.g001
Figure 2. Effect of the pulsed radiofrequency field on time course of hemoglobin deoxygenation. Time course of oxy hemoglobin
(HbO2) concentration, after a single 30 min pulsed radiofrequency electromagnetic field (PRF) exposure of Hb, under deoxygenating conditions.
Concentration was determined by visible light spectroscopy at 560, 576, 630 nm. PRF exposure resulted in a significant (30.8610.3)% reduction in
oxyHb concentration, as compared to controls (14.661.3 mM vs. 21.162.5 mM, P,0.03, n = 5), suggesting an alteration in Hb solution properties that
persisted after PRF signal was removed.
doi:10.1371/journal.pone.0061752.g002
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Figure 3. Addition of 5 M urea to reaction mixture. Addition of 5 M urea to the deoxygenation assay reduces the time required for
deoxygenation and render the PRF effect more apparent. The maximal difference between PRF-treated and control samples occurred at 73 min, with
PRF-treated samples showing a significant (70.469.7)% reduction in oxyHb concentration, as compared to controls (8.562.1 mM vs. 28.866.3 mM,
P,0.03, n = 5), in contrast to the 30.8% reduction observed in the absence of urea (cf. Figure 2).
doi:10.1371/journal.pone.0061752.g003
Figure 4. Effect of the static magnetic field on time course of hemoglobin deoxygenation. Hb deoxygenation after 10 min exposure to
186 mT static magnetic field (SMF) in 5M urea. No significant change in oxy/deoxy ratio was visible until the time of rapid deoxygenation, at
approximately 40 min. The time of most rapid deoxygenation occurred approximately 10 min earlier for SMF treated samples (P,0.002 for
42 min,t,58 min, n = 5).
doi:10.1371/journal.pone.0061752.g004
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suggests that more than one mechanism may be responsible for the
results reported here. Although direct action on ferrous heme [28]
or free radical lifetimes [29,30] may account for the SMF effects
observed here, several other models have been proposed for weak,
mT-range magnetic field bioeffects [31]. We have previously
shown using the Lorentz-Langevin model that mT-range magnetic
fields may have an effect on the thermally activated orientation of
ionic oscillators and waters bound at the protein surface [32,33]
and that the minimum magnetic field required to directly compete
with thermal forces to affect dissociation of a bound ion or ligand
from a protein binding site is in the 1–10 mT-range [34]. Thus,
the effect of the mT-range magnetic field employed in this study
could occur by the direct action of the Lorentz force on charges
bound at the protein/water interface. Functionally important
hemoprotein molecular motions are slaved to the thermal
fluctuations of the bulk solvent [35] and protein hydration plays
a fundamental role in the stability of dynamics between Hb T-R
conformations [36] so that the PRF and SMF interactions
described above, acting at the protein/water interface, may
suggest a means by which EMF could modulate protein function.
The deoxygenating conditions employed here, using the
reducing agent DTT in an in vitro cell-free model, differ
substantially from those found in vivo. However, EMF-induced
changes in the structure and function of Hb and erythrocyte
suspensions shown by others [7–12,14] have been reported in vivo
and in aqueous solution (i.e. without chemical deoxygenating
agents), thus demonstrating an EMF sensitivity under physiolog-
ical conditions and in the absence of reducing agents. Enhanced
delivery of oxygen has been shown to reduce inflammation [37]
and enhance tissue repair [38] and at least one trial has reported
an EMF-induced increase in deoxyHb in an in vivo animal model
[12]. Allosteric modification of Hb has been suggested as a
clinically useful means of enhancing oxygen delivery [39], and is in
development for in vivo treatment of ischemia from stroke, cardiac
disease and diabetic ulcers [15]. Although much further work is
required to ascertain the clinical relevance of the results reported
here, enhanced oxygen delivery using PRF or SMF may be
important non-invasive, non-pharmacologic therapeutic modali-
ties by which clinically relevant EMF-mediated enhancement of
growth and repair processes can occur.
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